¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"reaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • gross stress reaction
    ´ëÀڱعÝÀÀ, ÃÑüÀû½ºÆ®·¹½º¹ÝÀÀ
  • hyperkinetic reaction
    ¿îµ¿°ú´Ù¹ÝÀÀ
  • hypersensitivity reaction
    °ú¹Î¹ÝÀÀ
  • hypnic reaction
    ¼ö¸é¹ÝÀÀ
  • hysteric reaction
    È÷½ºÅ׸®¹ÝÀÀ
  • hemagglutination-inhibition reaction
    ÀûÇ÷±¸ÀÀÁý¾ïÁ¦¹ÝÀÀ
  • hemoclastic reaction
    Ç÷±¸ÆÄ±«¹ÝÀÀ
  • hemolytic transfusion reaction
    ¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • Herxheimer¡¯s reaction
    Ç츣ũ½ºÇÏÀ̸ӹÝÀÀ
  • heterogeneous reaction
    ÀÌÁú¹ÝÀÀ
  • heterophil antibody reaction
    ÀÌÁ¾Ä£È­Ç×ü¹ÝÀÀ
  • homograft reaction
    µ¿Á¾À̽ĹÝÀÀ
  • hopping reaction
    µµ¾à¹ÝÀÀ, ¾Ó°¨Áú¹ÝÀÀ
  • humoral reaction
    ü¾×¹ÝÀÀ
  • involutional depressive reaction
    °»³â±â¿ì¿ï¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • foot placement reaction
    ¹ß³õ±â¹ÝÀÀ
  • footpad reaction
    ¹ß¹Ù´Ú¹ÝÀÀ
  • fuchsin number reaction
    Ç«½Å¼ö¹ÝÀÀ
  • fuchsinophil reaction
    Ç«½Åģȭ¹ÝÀÀ
  • gel diffusion precipitin reaction
    ¿ì¹«È®»êħÀü¹ÝÀÀ
  • gluteal reaction
    º¼±â¹ÝÀÀ
  • graft versus host reaction
    ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀ
  • grief reaction
    ¾Öµµ¹ÝÀÀ, ºñ¾Ö¹ÝÀÀ
  • gross stress reaction
    ´ëÀڱعÝÀÀ, ÃÑüÀû½ºÆ®·¹½º¹ÝÀÀ
  • hemagglutination-inhibition reaction
    ÀûÇ÷±¸ÀÀÁý¾ïÁ¦¹ÝÀÀ
  • hemoclastic reaction
    Ç÷±¸ºØ±«¹ÝÀÀ
  • hemolytic transfusion reaction
    ¿ëÇ÷¼öÇ÷¹ÝÀÀ
  • Herxheimer¡¯s reaction
    (¢¡Jarisch-Herxheimer reaction) ¾ß¸®½ÃÇ츤½ºÇÏÀ̸ӹÝÀÀ
  • heterogeneous reaction
    ºÒ±ÕÀϹÝÀÀ, ºÒ±ÕÁú¹ÝÀÀ
  • heterophil antibody reaction
    ÀÌÁ¾Ä£È­Ç×ü¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • phasic reaction
    (À§)»ó¹ÝÀÀ(êÈßÓÚãëë).
  • phobic reaction
    °øÆ÷¹ÝÀÀ(¡­Úãëë).
  • photoallergic reaction
    ±¤(ÎÃ)¾Ë·¹¸£±â¹ÝÀÀ.
  • photoallergic reaction
    ±¤(ÎÃ)¾Ë·¹¸£±â¹ÝÀÀ
  • photochemical reaction
    ±¤È­ÇйÝÀÀ.
  • photodynamic reaction
    ±¤¿ªÇйÝÀÀ.
  • photolytic reaction
    ±¤Àü¹ÝÀÀ(ÎÃï³Úãëë).
  • photosensitivity reaction
    ±¤¼±°ú¹ÎÁõ¹ÝÀÀ(ÎÃàÊΦÚÂñøÚãëë).
  • phrenic reaction
    Ⱦ°Ý¸·¹ÝÀÀ(¡­Úãëë).
  • pilomotor reaction
    ¸ð¹ß¿îµ¿¹ÝÀÀ(¡­ê¡ÔÑ Úãëë).
  • pilomotor reaction
    ¸ð¹ß¿îµ¿¹ÝÀÀ(¡­ê¡ÔÑ Úãëë)
  • placing reaction
    ¹ßµÎ±â¹ÝÀÀ(¡­Úãëë).
  • pneumococcal capsular swelling reaction
    Æó·Å±¸±Õ Çù¸·ÆØÃ¢¹ÝÀÀ
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • downgrading reaction
    ÇÏÇ⼺ ¹ÝÀÀ
  • drug reaction
    ¾à¹° ¹ÝÀÀ
  • drug reaction
    ¾à¹°¹ÝÀÀ
  • dry reaction
    °Ç½Ä¹ÝÀÀ(ËëãÒÚãëë).
  • early reaction
    Á¶±â¹ÝÀÀ.
  • early reaction
    Á¶±â¹ÝÀÀ
  • electronic reaction
    ÀüÀÚ¹ÝÀÀ.
  • elementary reaction
    ±âº»¹ÝÀÀ.
  • elevator reaction
    ½Â°­±â¹ÝÀÀ(ã°Ë½Ñ¦Úãëë).
  • emergency reaction
    ±ä±Þ¹ÝÀÀ.
  • endoergic reaction
    ³»Àμº¹ÝÀÀ
  • endothermic reaction
    Èí¿­¹ÝÀÀ(ýåæðÚãëë).
  • enzyme-antienzyme reaction
    È¿¼ÒÇ×È¿¼Ò¹ÝÀÀ.
  • eosinophilic leukemoid reaction
    È£»ê±¸¼º ¹éÇ÷º´¾ç¹ÝÀÀ
  • erythremoid reaction
    ÀûÇ÷º´¾ç¹ÝÀÀ.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • specific reaction rate
    ƯÀÌ ¹ÝÀÀ¼Óµµ(÷åì¶ÚãëëáÜÓø)
  • spontaneous reaction
    "Àڹ߹ÝÀÀ(í»Û¡Úãëë), ÀúÀý·Î ¹ÝÀÀ(Úãëë)"
  • spreading reaction
    ÆÛÁü ¹ÝÀÀ(Úãëë)
  • staircase reaction
    °è´Ü ¹ÝÀÀ(Í­Ó«Úãëë)
  • standard reaction conditions
    Ç¥ÁØ ¹ÝÀÀÁ¶°Ç(øöñÞÚãëëðÉËì)
  • stereoselective reaction
    ÀÔü¼±Åà ¹ÝÀÀ(Ø¡ô÷àÔ÷ÉÚãëë)
  • stereospecific reaction
    ÀÔü ƯÀÌÀû ¹ÝÀÀ (Ø¡ô÷÷åì¶îÜÚãëë)
  • Stickland reaction
    ½ºÆ½Å¬·£µå ¹ÝÀÀ(Úãëë)
  • substitution reaction
    ġȯ ¹ÝÀÀ(öÇüµÚãëë)
  • Sullivan reaction
    ¼³¸®¹Ý ¹ÝÀÀ(Úãëë)
  • synchronous reaction
    µ¿Á¶¹ÝÀÀ (ÔÒðàÚãëë)
  • termolecular reaction
    »ïºÐÀÚ¹ÝÀÀ (ß²ÝÂí­Úãëë)
  • terreactant reaction
    »ï¹ÝÀÀ¹° ¹ÝÀÀ (ß²ÚãëëÚªÚãëë)
  • theory of absolute reaction rates
    Àý´ë¹ÝÀÀ¼Óµµ ÀÌ·Ð (ï¾ÓßÚãëëáÜÓøì¶Öå)
  • thermonuclear reaction
    ¿­ÇÙ¹ÝÀÀ (æðú·Úãëë)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
CR calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio...
CRD carbohydrate-recognition domain; chronic renal disease; chronic respiratory disease; child restraint...
CRI Cardiac Risk Index; catheter-related infection; chronic renal insufficiency; chronic respiratory ins...
CSF-WR cerebrospinal fluid-Wassermann reaction
DER disulfiram-ethanol reaction; dual energy radiography
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
nPCR Nested polymerase chain reaction
nested PCR Nested polymerase chain reaction
OTR Ocular Tilt Reaction
PAS Periodic Acid-Schiff reaction
PCR Polimerase Chain Reaction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • skin reaction
    ÇǺΠ¹ÝÀÀ
  • successive reaction
    ¹Ýº¹ ¹ÝÀÀ
  • toxic reaction
    µ¶ ¹ÝÀÀ, Áßµ¶ ¹ÝÀÀ
  • toxin antitoxin reaction
    µ¶¼Ò-Ç×µ¶¼Ò ¹ÝÀÀ
  • trimolecular reaction
    »ï ºÐÀÚ ¹ÝÀÀ
  • tuberculin reaction
    tuberculin ¹ÝÀÀ, Åõº£¸£Ä𸰠¹ÝÀÀ
  • two-phase color reaction
    µÎ °¡Áö »ö±ò ¹ÝÀÀ
  • uniphasic reaction
    ´Ü»ó ¹ÝÀÀ
  • untoward reaction
    ¹Ù¶÷Á÷ÇÏÁö ¾Ê´Â ¹ÝÀÀ
  • vaccinoid reaction
    °¡µÎ¼º ¹ÝÀÀ
  • vascular reaction
    Ç÷°ü ¹ÝÀÀ
  • waking reaction
    °¢¼º ¹ÝÀÀ
  • wheal reaction
    µÎµå·¯±â ¹ÝÀÀ, ÆØÁø ¹ÝÀÀ
  • xanthydrol reaction
    À鯼µå·Ñ ¹ÝÀÀ
  • zona reaction
    Åõ¸í´ë ¹ÝÀÀ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
constitutional reaction A generalised reaction in contrast to a focal or local reaction; in allergy the immediate or delayed response, following the introduction of an allergen, occurring at sites remote from that of injection.
(05 Mar 2000)
conversion reaction A conversion of emotional stress or mental disturbance into a physical symptom.
Examples include paralysis, blindness, inability to speak or another sudden debilitating problem for no reason evident through testing.
(27 Sep 1997)
coombs' reaction An immunological lab test to detect antibodies which attack the red blood cells of its own body (called autoantibodies). The test is important to the diagnosis of certain blood disorders. The test first reacts red blood cells with serum from the test individual, then with antibodies to the autoantibodies. If the autoantibodies exist, they will bind to the red blood cells. When the antibodies to the autoantibodies are added, they will bind the autoantibodies (still attached to the red blood cells) and cause the red blood cells to clump together. Large clumps of red blood cells indicate that the autoantibodies exist, absence of the clumps indicates that they don't.
(09 Oct 1997)
myasthenic reaction Rapid loss of response to faradic stimulation of a muscle with the galvanic response and the power of voluntary contraction retained.
Synonym: myasthenic reaction.
(05 Mar 2000)
cortical reaction The reaction of an egg cell to fertilization which changes its surface cell membrane and prevents additional sperm cells from entering (among other things).
(09 Oct 1997)
polymerase chain reaction <molecular biology, technique> The first practical system for in vitro amplification of DNA and as such one of the most important recent developments in molecular biology.
Two synthetic oligonucleotide primers, which are complementary to two regions of the target DNA (one for each strand) to be amplified, are added to the target DNA (that need not be pure), in the presence of excess deoxynucleotides and Taq polymerase, a heat stable DNA polymerase. In a series (typically 30) of temperature cycles, the target DNA is repeatedly denatured (around 90_C), annealed to the primers (typically at 50-60_C) and a daughter strand extended from the primers (72_C). As the daughter strands themselves act as templates for subsequent cycles, DNA fragments matching both primers are amplified exponentially, rather than linearly.
The original DNA need thus be neither pure nor abundant and the polymerase chain reaction has accordingly become widely used not only in research, but in clinical diagnostics and forensic science.
Acronym: PCR
(14 Oct 1997)
myelocytic leukemoid reaction Leukocytosis of at least moderate degree, e.g., 50,000 or more per cu mm, with a few immature forms, e.g., 1 or 2% myelocytes, but chiefly mature polymorphonuclear leukocytes in the circulating blood; may be observed in association with tuberculosis, chronic osteomyelitis, various types of empyema, malaria, pneumococcal pneumonia, meningococcal meningitis, Hodgkin's disease, and metastases of carcinoma in the bone marrow.
(05 Mar 2000)
coupled reaction Two chemical reactions that share a common intermediate (for example, the productof the first reaction is a reactant in the second) and therefore havesome kind of energy exchange between them.
(09 Oct 1997)
Porter-Silber reaction The basis of the 17-hydroxycorticosteroid test; C-21 adrenocorticosteroids, which contain a dihydroxyacetone group at carbons 19, 20, and 21, react with phenylhydrazine.
(05 Mar 2000)
Haber-Weiss reaction The reaction of superoxide (O2-- with hydrogen peroxide to produce molecular oxygen (O2), hydroxide radical (OH-), and OH-; often, iron catalyzed; a source of oxidative stress in blood cells and various tissues.
(05 Mar 2000)
cross reaction <haematology, immunology> Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen.
(12 Dec 1998)
haemoclastic reaction Haemolysis as observed in the laking of the blood.
(05 Mar 2000)
cutaneous graft versus host reaction An acute erythematous maculopapular reaction with bulla formation in the most severe cases; chronic changes may resemble lichen planus or scleroderma.
(05 Mar 2000)
cutaneous reaction The inflammatory reaction in the case of a skin test in a sensitive (allergic) subject.
Synonym: cutaneous reaction.
Origin: L. Cutis, skin, + reaction
(05 Mar 2000)
Prausnitz-Kustner reaction A test for the presence of immediate hypersensitivity in humans; test serum from an atopic individual is injected intradermally into a normal subject; the normal subject is challenged 24-48 hours later with the antigen suspected of causing the immediate hypersensitivity reaction in the atopic individual.
Synonym: P-K test.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á